Hepatobiliary Scintigraphy and Glass

hepatobiliary scintigraphy liver mebrofenin selective internal radiation therapy

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
21 May 2021
Historique:
received: 23 04 2021
revised: 13 05 2021
accepted: 18 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

The functional changes that occur over time in the liver following November 2016-October 2019: we retrospectively included hepatocellular carcinoma (HCC) patients treated by There were 16 patients with unilobar disease (100%) included, and 64 HBS were performed. Whole liver function significantly decreased over time. The loss was maximal at 2 weeks: -32% ( RE using PD induces significant regional changes in liver function over time. As early as 15 days following RE, both the treated and nontreated livers showed a decreased function. Nontreated liver function recovered after 3 months and greatly increased afterwards.

Sections du résumé

BACKGROUND BACKGROUND
The functional changes that occur over time in the liver following
METHODS METHODS
November 2016-October 2019: we retrospectively included hepatocellular carcinoma (HCC) patients treated by
RESULTS RESULTS
There were 16 patients with unilobar disease (100%) included, and 64 HBS were performed. Whole liver function significantly decreased over time. The loss was maximal at 2 weeks: -32% (
CONCLUSION CONCLUSIONS
RE using PD induces significant regional changes in liver function over time. As early as 15 days following RE, both the treated and nontreated livers showed a decreased function. Nontreated liver function recovered after 3 months and greatly increased afterwards.

Identifiants

pubmed: 34064296
pii: diagnostics11060931
doi: 10.3390/diagnostics11060931
pmc: PMC8224303
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Hepatol. 2019 Dec;71(6):1164-1174
pubmed: 31421157
J Nucl Med. 2019 Oct;60(10):1430-1436
pubmed: 30954942
J Nucl Med. 2010 Feb;51(2):229-36
pubmed: 20080899
Liver Int. 2004 Apr;24(2):117-23
pubmed: 15078475
EJNMMI Res. 2017 Dec;7(1):2
pubmed: 28058660
J Vasc Interv Radiol. 2018 Dec;29(12):1662-1670.e4
pubmed: 30217745
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):392-401
pubmed: 29177870
Radiology. 2020 Sep;296(3):673-684
pubmed: 32602828
HPB (Oxford). 2016 Sep;18(9):773-80
pubmed: 27593595
HPB (Oxford). 2016 Jun;18(6):494-503
pubmed: 27317953
Cancers (Basel). 2020 Jun 12;12(6):
pubmed: 32545572
World J Hepatol. 2020 Dec 27;12(12):1239-1257
pubmed: 33442451
Curr Oncol Rep. 2020 May 16;22(6):59
pubmed: 32415401
Hepatology. 2017 Sep;66(3):969-982
pubmed: 28407278
Diagnostics (Basel). 2020 Dec 23;11(1):
pubmed: 33374810
Lancet Oncol. 2017 Dec;18(12):1624-1636
pubmed: 29107679
J Clin Oncol. 2018 Jul 1;36(19):1913-1921
pubmed: 29498924
Am J Roentgenol Radium Ther Nucl Med. 1954 May;71(5):826-34
pubmed: 13148429
EJNMMI Res. 2019 Jul 22;9(1):62
pubmed: 31332585
J Vasc Interv Radiol. 2021 Jun;32(6):843-844
pubmed: 33689832
J Hepatol. 2013 Nov;59(5):1029-36
pubmed: 23811303
Front Oncol. 2014 Jun 16;4:152
pubmed: 24982851
J Surg Oncol. 2016 Jul;114(1):99-105
pubmed: 27103352
J Gastrointest Surg. 2010 Feb;14(2):369-78
pubmed: 19937195
Liver Int. 2017 Jan;37(1):101-110
pubmed: 27514012
Liver Int. 2015 May;35(5):1590-6
pubmed: 24836705
Surgery. 2017 Oct;162(4):775-783
pubmed: 28732555
Nucl Med Commun. 2020 Aug;41(8):740-749
pubmed: 32649575
Br J Surg. 2011 Jun;98(6):825-34
pubmed: 21484773
Am J Roentgenol Radium Ther Nucl Med. 1973 Jan;117(1):73-80
pubmed: 4685535
Gastroenterology. 2016 Dec;151(6):1155-1163.e2
pubmed: 27575820
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1695-1704
pubmed: 31098749
Hepatology. 1986 Mar-Apr;6(2):225-34
pubmed: 3514407
Hepatobiliary Surg Nutr. 2020 Oct;9(5):564-576
pubmed: 33163507
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):838-848
pubmed: 31956945
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29
pubmed: 33166497
Cancer. 2008 Apr 1;112(7):1538-46
pubmed: 18260156

Auteurs

Carole Allimant (C)

Department of Radiology, St-Eloi University Hospital, 34000 Montpellier, France.

Emmanuel Deshayes (E)

Department of Nuclear Medicine, Institut du Cancer Montpellier, 34000 Montpellier, France.

Marilyne Kafrouni (M)

Department of Nuclear Medicine, University Hospital Montpellier, 34000 Montpellier, France.

Lore Santoro (L)

Department of Nuclear Medicine, Institut du Cancer Montpellier, 34000 Montpellier, France.

Delphine de Verbizier (D)

Department of Nuclear Medicine, University Hospital Montpellier, 34000 Montpellier, France.

Marjolaine Fourcade (M)

Department of Nuclear Medicine, University Hospital Montpellier, 34000 Montpellier, France.

Christophe Cassinotto (C)

Department of Radiology, St-Eloi University Hospital, 34000 Montpellier, France.

Margaux Hermida (M)

Department of Radiology, St-Eloi University Hospital, 34000 Montpellier, France.

Chloé Guillot (C)

Department of Radiology, St-Eloi University Hospital, 34000 Montpellier, France.

Denis Mariano-Goulart (D)

Department of Nuclear Medicine, University Hospital Montpellier, 34000 Montpellier, France.

Boris Guiu (B)

Department of Radiology, St-Eloi University Hospital, 34000 Montpellier, France.

Classifications MeSH